Luliconazole

CAS 187164-19-8

Visão geral

Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan

A Anant Labs fabrica e fornece impurezas de Luliconazole de alta qualidade para o mercado global. Nossas impurezas EP de Luliconazole são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Em Estoque

Luliconazole

CAS 187164-19-8Em Estoque

Dados Técnicos

CAS187164-19-8

Fórmula Mol.C₁₄H₉Cl₂N₃S₂

Peso Mol.354.287 g/mol

IUPAC(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile

SMILESC1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl

InChIInChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1

Chave InChIYTAOBBFIOAEMLL-REQDGWNSSA-N

Note: We are upgrading our system, Cat No will change.

Sinônimos

Luliconazole187164-19-8LuliconNND-502LuzuPR-2699NND502luliconazol(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrileDTXSID3048607